COMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Compass Inc (COMP) is not a strong buy for a beginner, long-term investor at this time. While the company has shown revenue growth and hedge funds are increasing their positions, the stock faces significant headwinds, including a bearish technical setup, declining analyst price targets, and ongoing concerns about the housing market recovery. The lack of strong trading signals and the absence of positive momentum in its financial performance further support a cautious approach.
The technical indicators for COMP suggest a bearish trend. The MACD is positive and expanding, indicating some short-term momentum, but the RSI is neutral at 53.161, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 7.473 and 7.756, while support levels are at 6.561 and 6.278. The stock is trading close to its pivot point of 7.017, showing limited upside potential in the near term.
Hedge funds are significantly increasing their positions, with a 193.14% increase in buying over the last quarter.
Revenue growth of 23.14% YoY in Q4 2025 indicates some operational strength.
Declining analyst price targets, with multiple firms lowering their targets from $15 to $9-$12, reflecting a cautious outlook on the stock.
Concerns about the housing market recovery and affordability challenges, as highlighted by analysts.
Post-merger stock decline and ongoing securities investigation, which may weigh on investor sentiment.
EPS dropped by 12.50% YoY, and net income remains negative, signaling profitability challenges.
In Q4 2025, Compass reported revenue growth of 23.14% YoY, reaching $1.7 billion. However, net income remains negative at -$42.6 million, albeit improving by 5.19% YoY. EPS dropped to -0.07, down 12.50% YoY, while gross margin increased to 16.97%, up 5.80% YoY. Despite revenue growth, profitability metrics remain weak.
Analysts are mixed to cautious on COMP. Recent ratings include multiple price target reductions (e.g., BTIG, Barclays, and Wells Fargo lowering targets to $9-$12) and concerns about the housing market recovery. However, some analysts, like Benchmark, maintain a Buy rating with a $14 target, citing long-term opportunities in the residential real estate market.
